News from novelos therapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 16, 2013, 08:30 ET

Novelos Therapeutics Provides Product Pipeline Update

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer,...

Feb 21, 2013, 08:30 ET

Novelos Therapeutics Closes $5.5 Million Public Offering

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Feb 13, 2013, 08:30 ET

Novelos Therapeutics Prices $5.5 Million Public Offering

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Feb 04, 2013, 08:30 ET

Novelos Therapeutics To Present At The 15th Annual BIO CEO & Investor Conference On February 11

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Jan 31, 2013, 08:30 ET

Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Nov 27, 2012, 08:30 ET

Novelos Therapeutics To Present At The Benchmark 2012 Micro Cap Discovery Investor Conference On November 29

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Nov 05, 2012, 08:30 ET

Novelos Therapeutics Closes $2 Million Private Placement

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Oct 25, 2012, 08:30 ET

Novelos Therapeutics Announces Enrollment of First Patient in Solid Tumor Imaging Trial with I-124-CLR1404 (LIGHT) Cancer-targeted PET Imaging Agent at UW Carbone Cancer Center

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Oct 03, 2012, 08:30 ET

Novelos Therapeutics and Academic Collaborators Present Diapeutic Technology Platform at Imaging in 2020 Conference

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer,...

Oct 02, 2012, 08:30 ET

Novelos Therapeutics to Present at 11th Annual Bio Investor Forum on October 10

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Sep 11, 2012, 08:30 ET

Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Sep 07, 2012, 08:30 ET

Novelos Therapeutics And Academic Collaborators Present Three Posters At 2012 World Molecular Imaging Congress

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Sep 04, 2012, 08:30 ET

Novelos Therapeutics to Present at Rodman & Renshaw 14th Annual Healthcare Conference on September 11

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Aug 28, 2012, 08:30 ET

Novelos Therapeutics Developing CLR1502 (GLOW2) Cancer-Targeted Optical Imaging Agent For Intraoperative Tumor Margin Illumination

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Jun 27, 2012, 08:30 ET

Novelos Therapeutics to Present at LHA Life Sciences & Medical Technologies Virtual Conference on June 28

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Jun 19, 2012, 08:30 ET

Novelos Therapeutics Announces Positive Initial Imaging Results In Brain Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent At UW Carbone Cancer Center

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Jun 14, 2012, 08:30 ET

Novelos Therapeutics Closes $5.4 Million Public Offering

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer,...

Jun 08, 2012, 08:30 ET

Novelos Therapeutics Prices $5.4 Million Public Offering

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

May 15, 2012, 08:30 ET

Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic

Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today...

Apr 24, 2012, 08:30 ET

Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center

 Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today...